Drug Profile
V 114
Alternative Names: 15-valent pneumococcal conjugate vaccine; 15-valent pneumococcal conjugate vaccine - Merck; Bacnuvans; CRM197 - Merck; MK-V114; PCV-15; Pneumococcal vaccine conjugate 15 valent; Pneumococcal vaccine conjugate 15 valent - Merck; V114; V114 aluminum-adjuvanted; VAXNEUVANCELatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Conjugate vaccines; Glycoconjugates; Pneumococcal vaccines; Polysaccharides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pneumococcal infections